U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06854406) titled 'A Study of Varenicline in the Treatment of Visceral Sensation' on Feb. 21.
Brief Summary: The purpose of this study'is to evaluate the effect of varenicline on rectal sensation, based on ascending method of limits and on graded rapid phasic distensions in participants with non-constipation IBS and chronic abdominal pain.'
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Irritable Bowel Syndrome
Intervention:
DRUG: Varenicline
Initial, 0.5 mg orally once daily for 3 days, then 0.5 mg every 12 hours on days 4 through 7, and then 1 mg in morning of day 8. Medication is taken after eating and with a full glass of ...